Prestige Consumer Healthcare Inc. provided earnings guidance for the second quarter and full fiscal year 2023. Second quarter revenues are anticipated to be approximately $283 million, an increase of about 2.5% versus the prior year. For Second quarter, EPS is expected to be between $0.98 and $1.
For fiscal year 2023, the company continue to anticipate revenue growth of approximately 3% to 4%, $1,120 million to 1,130 million, including organic revenue growth of 2% to 3%, consistent with long-term target. Company also continue to anticipate Diluted EPS of $4.18 to $4.23 for fiscal 2023.